Rebus Holdings, Inc. is a pharmaceutical company engaged in the research and development of novel therapeutics for the treatment of cancer. Its product pipeline includes Mipsagargin, a dual A2A/A2B antagonist, an A2A antagonist, an A2B antagonist, and an A2A agonist. The company was founded by Craig A. Dionne, John T. Issacs, and Samuel R. Denmeade on November 21, 2003 and is headquartered in Westlake Village, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Rebus Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rebus Holdings Inc market cap is $3,200.00.
What is the 52-week high for Rebus Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rebus Holdings Inc 52 week high is $0.0002 as of September 12, 2025.
What is the 52-week low for Rebus Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rebus Holdings Inc 52 week low is $0.00 as of September 12, 2025.
What is Rebus Holdings Inc stock price today?
Rebus Holdings Inc stock price today is $0.0001.
What was Rebus Holdings Inc stock price yesterday?
Rebus Holdings Inc stock price yesterday was $0.0001.
What is the 50-day moving average of Rebus Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rebus Holdings Inc 50-day moving average is $0.0001.